Chroma Medicine and Nvelop Therapeutics Unite to Form nChroma Bio, Securing $75 Million to Accelerate Genetic Medicines [Yahoo! Finance]
Janus Henderson Group plc Ordinary Shares (JHG)
Last janus henderson group plc ordinary shares earnings: 4/30 04:00 am
Check Earnings Report
US:NYSE Investor Relations:
snl.com/irw/corporateprofile/4147331
Company Research
Source: Yahoo! Finance
nChroma's lead program, CRMA-1001, is a liver-targeted epigenetic editing therapy with potential for both best-in-class potency and ability to drive functional cures for chronic hepatitis B and hepatitis D The combination of highly potent therapeutic cargos and efficient in vivo targeted delivery will enable a robust product engine and pipeline Consolidated company to be led by CEO Jeff Walsh; Jeff Marrazzo appointed Chairman of the Board BOSTON & CAMBRIDGE, Mass., December 11, 2024 BUSINESS WIRE )--Chroma Medicine and Nvelop Therapeutics today announced their merger and subsequent launch of nChroma Bio ("nChroma" or "the company") to redefine the future of genetic medicines. nChroma brings together potent epigenetic editing plus non-viral, programmable delivery to address key limitations in the field and expand the scope of treatable diseases. The merger results in an industry-leading company with a deeply experienced team. Jeff Walsh will serve as nChroma's CEO and Jeff Marra
Show less
Read more
Impact Snapshot
Event Time:
JHG
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
JHG alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
JHG alerts
High impacting Janus Henderson Group plc Ordinary Shares news events
Weekly update
A roundup of the hottest topics
JHG
News
- Janus Henderson Group plc (NYSE: JHG) had its price target raised by analysts at Morgan Stanley from $46.00 to $48.00. They now have an "equal weight" rating on the stock.MarketBeat
- Sony's Record Climb Makes Investors More Bullish on Gaming Boom [Yahoo! Finance]Yahoo! Finance
- Directorate change [Yahoo! Finance]Yahoo! Finance
- Ottimo Pharma Raises over $140 Million in Series A Financing [Yahoo! Finance]Yahoo! Finance
- Morning Bid: Fed's 'hawkish cut' slams markets, BOJ up next [Yahoo! Finance]Yahoo! Finance
JHG
Earnings
- 10/31/24 - Beat
JHG
Sec Filings
- 11/14/24 - Form 13F-HR
- 11/14/24 - Form SC
- 11/8/24 - Form 3
- JHG's page on the SEC website